Endovascular Today

iVascular’s Luminor DCB for Femoropopliteal Disease Evaluated in LUMIFOLLOW Registry

March 18, 2026—iVascular announced 3-year follow-up results from the LUMIFOLLOW registry, a large real-world study evaluating ...
Healio

Directional atherectomy followed by DCB effective to treat complex peripheral lesions

Please provide your email address to receive an email when new articles are posted on . Brian G. DeRubertis, MD, FACS, professor of surgery in the division of vascular and endovascular surgery at the ...
Business Wire

Surmodics Receives FDA Approval for the SurVeil™ Drug-Coated Balloon

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the receipt ...
Healio

FDA panel does not recommend approval of DCB for below-the-knee lesions

Please provide your email address to receive an email when new articles are posted on . The FDA’s Circulatory System Devices Panel voted not to recommend approval of a drug-coated balloon to treat ...
Medscape

Vascular Disease News

ACC 2022 Sweet Success for Chocolate Touch DCB in Femoropopliteal Disease The paclitaxel-coated balloon with a quirky design and confectionery name achieved better patency outcomes and noninferiority ...